Katrin Pfutze
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 23 publications
17.6% of patients in a German cohort with exocrine pancreatic cancer were diagnosed with a genetic tumor syndrome-a case for universal genetic testing?
Journal: ESMO gastrointestinal oncology
Published: February 06, 2026
Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms.
Journal: Med (New York, N.Y.)
Published: July 27, 2025
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling-The CATCH experience.
Journal: International journal of cancer
Published: June 27, 2025
Metavert synergises with standard cytotoxics in human PDAC organoids and is associated with transcriptomic signatures of therapeutic response.
Journal: Translational oncology
Published: March 18, 2024
Signaling-induced systematic repression of miRNAs uncovers cancer vulnerabilities and targeted therapy sensitivity.
Journal: Cell reports. Medicine
Published: December 19, 2022
Proteogenomic analysis reveals RNA as a source for tumor-agnostic neoantigen identification.
Journal: Nature communications
Published: September 27, 2022
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.
Journal: ESMO open
Published: August 03, 2022
Comprehensive cancer predisposition testing within the prospective MASTER trial identifies hereditary cancer patients and supports treatment decisions for rare cancers.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: March 06, 2022
Comprehensive genomic and epigenomic analysis in cancer of unknown primary guides molecularly-informed therapies despite heterogeneity.
Journal: Nature communications
Published: March 05, 2021
Last Updated: 09/26/2026